April 8, 2014
Posted January 26, 2016
The SEC charged CVS Caremark Corp. with misleading investors about significant financial setbacks and using improper accounting that artificially boosted its financial performance. CVS agreed to pay $20M to settle the charges. SEC
Tagged in: Accounting Fraud, Securities Fraud,